Dr. Catharine Paddock’s article for Medical News Today, “PET scans can help select best TB drugs for trials,” reveals advantages of scanning primates versus mice due to similar disease profiles shared by human and primate. In a study led by the University of Pittsburgh School of Medicine, linezolid, a drug developed to treat extensively drug-resisistant tuberculosis (XDR-TB), was found to be effective in humans and macaques using PET/CT scans, although earlier studies on mice showed no effect.
X-Z LAB’s small animal PET technology allows small animals as well as not-so-small animals to be scanned, thereby improving the preclinical process. The Trans-PET® BioCaliburn® occupies this niche within a niche and delivers the unique ability to scan multiple mice simultaneously or single primates.